Point of Care Testing (POCT) refers to diagnostic testing performed near the patient, typically at or near the bedside, rather than in a central laboratory. POCT provides rapid results, allowing for immediate clinical decision-making and treatment adjustments. This approach is particularly valuable in emergency situations, remote or resource-limited settings, and for monitoring chronic conditions. POCT devices are compact, portable, and easy to use, enabling testing by non-laboratory personnel with minimal training. Common examples of POCT include blood glucose monitoring for diabetes management, rapid infectious disease testing (e.g., influenza, HIV), and cardiac biomarker testing for acute myocardial infarction. POCT devices utilize various technologies such as lateral flow assays, biosensors, immunoassays, and molecular diagnostics to detect and quantify analytes in biological samples. Quality assurance measures, including proficiency testing and external quality assessment, are essential to ensure the accuracy and reliability of POCT results. Collaboration between clinicians, laboratory professionals, manufacturers, and regulatory agencies is critical for the development, implementation, and standardization of POCT programs. Continuous advancements in technology, device miniaturization, and connectivity enhance the capabilities and accessibility of POCT, improving patient outcomes and healthcare delivery.
Title : Advances in plasma-based waste treatment for sustainable communities
Hossam A Gabbar, Ontario Tech University, Canada
Title : Nanostructured biodevices based on carbon nanotubes and glyconanoparticles for bioelectrocatalytic applications
Serge Cosnier, Silesian University of Technology, Poland
Title : Carbon capture and storage: The impact of impurities in CO2 streams
Andy Brown, Progressive Energy Ltd, United Kingdom
Title : Supramolecular nano chemistries: Fighting viruses, inhibiting bacteria and growing tissues
Thomas J Webster, Hebei University of Technology, China
Title : Chemical engineering of vanadium and tantalum zeolites for application in environmental catalysis
Stanislaw Dzwigaj, Sorbonne Universite, France
Title : Disrupting TNF-α and TNFR1 interaction: Computational insights into the potential of D-Pinitol as an anti-inflammatory therapeutic
Ferran Acuna Pares, Universidad Internacional de la Rioja (UNIR), Spain